MAPK10 and Alzheimer disease: It also modulated other targets involved in the pathogenesis of AD, including oxidative stress, atherosclerosis, and inflammation (BCL2, IKBKB, MAPK10, NOS3, TNF, PTGS2, and GSK3B).